{"entity":{"type":"insider","cik":"0001392029","url":"/insider/0001392029","json_url":"/insider/0001392029.json","name":"Davis Todd C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":14,"first":"2011-08-11","last":"2026-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Davis Todd C","source":"filing","n_filings":14,"first_seen":"2011-08-11","last_seen":"2026-06-15"}],"transactions":[{"id":5997901,"accession":"0001919246-26-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001919246-26-000088","line_url":"/filing/0001919246-26-000088","is_derivative":false,"issuer_cik":"0001392029","issuer_name":"Pelthos Therapeutics Inc.","issuer_ticker":"PTHS","issuer_name_source":null,"issuer_url":"/issuer/0001392029","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35948.0,"shares_display":"35,948","price_per_share":27.817494027484145,"price_display":"27.82","price_state":"stated","total_value":999983.2753,"total_display":"999,983.28","total_whole":"999,983","shares_owned_after":75331.0,"shares_owned_after_display":"75,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-15","scope":"insider","n_lines":2},{"id":4607599,"accession":"0002001011-25-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-25-000029","line_url":"/filing/0002001011-25-000029","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9510.0,"shares_display":"9,510","price_per_share":105.20045993690852,"price_display":"105.20","price_state":"stated","total_value":1000456.374,"total_display":"1,000,456.37","total_whole":"1,000,456","shares_owned_after":161234.0,"shares_owned_after_display":"161,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-13","scope":"insider","n_lines":3},{"id":2072984,"accession":"0002001011-24-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000067","line_url":"/filing/0002001011-24-000067#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":97.3922,"price_display":"97.39","price_state":"stated","total_value":243480.5,"total_display":"243,480.50","total_whole":"243,481","shares_owned_after":123010.0,"shares_owned_after_display":"123,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-09","scope":"insider"},{"id":7986764,"accession":"0000886163-23-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-23-000057","line_url":"/filing/0000886163-23-000057#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":59.3822,"price_display":"59.38","price_state":"stated","total_value":237528.8,"total_display":"237,528.80","total_whole":"237,529","shares_owned_after":73090.0,"shares_owned_after_display":"73,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-25","scope":"insider"},{"id":4866106,"accession":"0000886163-21-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-21-000035","line_url":"/filing/0000886163-21-000035#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5083.0,"shares_display":"5,083","price_per_share":213.1438,"price_display":"213.14","price_state":"stated","total_value":1083409.9354,"total_display":"1,083,409.94","total_whole":"1,083,410","shares_owned_after":47678.0,"shares_owned_after_display":"47,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":2742409,"accession":"0001103021-20-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-20-000140","line_url":"/filing/0001103021-20-000140#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":249500.0,"total_display":"249,500.00","total_whole":"249,500","shares_owned_after":217914.0,"shares_owned_after_display":"217,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2608857,"accession":"0001437749-20-009007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-009007","line_url":"/filing/0001437749-20-009007#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":3.275,"price_display":"3.28","price_state":"stated","total_value":196500.0,"total_display":"196,500.00","total_whole":"196,500","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-28","filed_date":"2020-04-30","scope":"insider"},{"id":7833496,"accession":"0001103021-19-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-19-000038","line_url":"/filing/0001103021-19-000038#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":6.11,"price_display":"6.11","price_state":"stated","total_value":1222000.0,"total_display":"1,222,000.00","total_whole":"1,222,000","shares_owned_after":237914.0,"shares_owned_after_display":"237,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-19","scope":"insider"},{"id":7991379,"accession":"0000886163-19-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000140","line_url":"/filing/0000886163-19-000140#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":93.5944,"price_display":"93.59","price_state":"stated","total_value":93594.4,"total_display":"93,594.40","total_whole":"93,594","shares_owned_after":49474.0,"shares_owned_after_display":"49,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-05","scope":"insider"},{"id":6088800,"accession":"0000886163-18-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-18-000145","line_url":"/filing/0000886163-18-000145#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":253.9912,"price_display":"253.99","price_state":"stated","total_value":634978.0,"total_display":"634,978.00","total_whole":"634,978","shares_owned_after":42556.0,"shares_owned_after_display":"42,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-08","filed_date":"2018-10-09","scope":"insider"},{"id":6592851,"accession":"0000886163-18-000122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-18-000122","line_url":"/filing/0000886163-18-000122#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3167.0,"shares_display":"3,167","price_per_share":239.5,"price_display":"239.50","price_state":"stated","total_value":758496.5,"total_display":"758,496.50","total_whole":"758,497","shares_owned_after":45056.0,"shares_owned_after_display":"45,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-17","scope":"insider"},{"id":6592848,"accession":"0000886163-18-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-18-000122","line_url":"/filing/0000886163-18-000122#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5833.0,"shares_display":"5,833","price_per_share":239.9289,"price_display":"239.93","price_state":"stated","total_value":1399505.2737,"total_display":"1,399,505.27","total_whole":"1,399,505","shares_owned_after":48223.0,"shares_owned_after_display":"48,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-17","scope":"insider"},{"id":6716479,"accession":"0000886163-18-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-18-000027","line_url":"/filing/0000886163-18-000027#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12335.0,"shares_display":"12,335","price_per_share":151.9018,"price_display":"151.90","price_state":"stated","total_value":1873708.703,"total_display":"1,873,708.70","total_whole":"1,873,709","shares_owned_after":53563.0,"shares_owned_after_display":"53,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-27","scope":"insider"},{"id":6716474,"accession":"0000886163-18-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-18-000027","line_url":"/filing/0000886163-18-000027#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4835.0,"shares_display":"4,835","price_per_share":153.5751,"price_display":"153.58","price_state":"stated","total_value":742535.6085,"total_display":"742,535.61","total_whole":"742,536","shares_owned_after":65898.0,"shares_owned_after_display":"65,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-27","scope":"insider"},{"id":6983858,"accession":"0000886163-14-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-14-000035","line_url":"/filing/0000886163-14-000035#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":79.6294,"price_display":"79.63","price_state":"stated","total_value":398147.0,"total_display":"398,147.00","total_whole":"398,147","shares_owned_after":32536.0,"shares_owned_after_display":"32,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-20","scope":"insider"},{"id":6983855,"accession":"0000886163-14-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-14-000035","line_url":"/filing/0000886163-14-000035#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":79.4549,"price_display":"79.45","price_state":"stated","total_value":198637.25,"total_display":"198,637.25","total_whole":"198,637","shares_owned_after":37536.0,"shares_owned_after_display":"37,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-20","scope":"insider"},{"id":8991520,"accession":"0000886163-11-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-11-000059","line_url":"/filing/0000886163-11-000059#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392029","owner_name":"Davis Todd C","owner_display_name":"Davis Todd C","owner_url":"/insider/0001392029","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":163500.0,"total_display":"163,500.00","total_whole":"163,500","shares_owned_after":29201.0,"shares_owned_after_display":"29,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-10","filed_date":"2011-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001919246","name":"Pelthos Therapeutics Inc.","url":"/issuer/0001919246","role":"Director","n_filings":1,"first_seen":"2026-06-15","last_seen":"2026-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2011-08-11","last_seen":"2025-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001103021","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","url":"/issuer/0001103021","role":"Director","n_filings":2,"first_seen":"2019-11-19","last_seen":"2020-08-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000072444","name":"Vaxart, Inc.","url":"/issuer/0000072444","role":"Director","n_filings":1,"first_seen":"2020-04-30","last_seen":"2020-04-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001392029","retrieved_at":"2026-08-25T17:20:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}